For research use only. Not for therapeutic Use.
<p style=/line-height:25px/>L-655708 is a potent α5 subunit-selective GABAA receptor inverse agonist (Ki = 0.45 nM).<br>IC50: 0.45 nM (Ki)<br>Target: GABA<br>in vitro: L-655708 is a potent, selective inverse agonist for the benzodiazepine site of GABAA receptors containing the α5 subunit (Ki = 0.45 nM). Displays 50-100-fold selectivity over GABAA receptors containing α1, α2, α3 orα6 subunits in combination with β3 and γ2. Enhances LTP in a mouse hippocampal slice model and increases spatial learning, without displaying proconvulsant activity.<br>in vivo: L-655708 at 0.7 mg/kg, administered intraperitoneally, would result in 60-70% occupancy of α5 GABAA receptors with limited binding to α1, α2, and α3 subunit-containing GABAA receptors and no significant off-target behavioral effects, such as sedation and motor impairment.[1]</p>
Catalog Number | I001168 |
CAS Number | 130477-52-0 |
Synonyms | (S)-ethyl 7-methoxy-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a][1,4]diazepine-1-carboxylate |
Molecular Formula | C18H19N3O4 |
Purity | ≥95% |
Target | Neuronal Signaling |
Solubility | 10 mM in DMSO |
Storage | Desiccate at +4C |
Reference | <p style=/line-height:25px/> </p> |